The science of cellular aging: NAD+, growth hormone, and methylation



Most articles about aging focus on a single fix: one molecule, one supplement, one pathway. The biology is more interesting than that. Aging reflects several interconnected changes happening in parallel, and understanding them is genuinely useful, both for making sense of how the body changes and for having an informed conversation with a provider.
Three of the most studied age-related changes are the decline of NAD+, the reduction in growth hormone signaling, and shifts in methylation. This is an educational overview of what each one is and how they relate. It isn't a claim about what any product will do for you.
NAD+ is a coenzyme that sits at the center of how cells produce energy. It's essential for the mitochondria, the parts of the cell that generate usable energy, and it's also a required input for sirtuins, a family of proteins involved in DNA regulation and repair.
Research indicates NAD+ levels change with age. That's an area of active scientific interest, which is why NAD+ is one of the pathways a provider-guided program may consider.
Growth hormone is produced by the pituitary gland and released in natural pulses. Like other hormones, its production naturally declines with age, a normal part of how the endocrine system changes over time.
Approaches in this area generally fall into two categories: adding hormone from outside, or working with the body's own pituitary signaling. Sermorelin falls into the second category. It's a growth hormone-releasing hormone (GHRH) analog that works with your own pituitary rather than replacing the hormone. Describing that mechanism is education; it isn't a promise of a specific result. Sermorelin is available as a compounded medication and is not FDA-approved.
Methylation is a biochemical process in which a methyl group is passed from one molecule to another. It's involved in DNA regulation, neurotransmitter production, and other cellular functions, and it depends on nutrients including B12, folate, methionine, and choline.
Because methylation touches so many processes, adequate nutrient status matters, which is the educational rationale behind nutrient-based support such as a B12/MIC injection.
These systems don't operate in isolation. NAD+ supports the sirtuins involved in cellular regulation; growth hormone signaling and methylation each depend on adequate cellular resources; and nutrient status underlies several of these processes at once.
The takeaway isn't that any one product resolves aging. It doesn't, and no responsible program would claim that. The point is that these pathways are related, which is why a clinician-guided program looks at more than one of them and evaluates, with you, which options (if any) are appropriate for your situation.
If the biology of aging interests you and you want to understand the clinician-guided options that address these pathways, the next step is to take the short Luvo questionnaire so we can help you find treatment that fits your needs. Explore Luvo's Longevity Program to learn more.